BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bioenergy, Inc. Release: A Unique Sugar May Be Key to Energizing the Failing Heart


3/22/2007 2:12:21 PM

MINNEAPOLIS, March 22 /PRNewswire-FirstCall/ -- Following the recent publication in the New England Journal of Medicine that the failing heart is an "engine out of fuel" (N ENGL J MED 356;11, March 15, 2007), Bioenergy Life Science reports that D-ribose, a simple, five-carbon sugar, is a plausible option for addressing the nation's heart disease epidemic.

"When heart failure develops, many factors are involved, but energy deprivation is among the most important," said John St. Cyr, MD, PhD, the medical director of Bioenergy Life Science. "We've learned recently that patients with heart disease may have a deficient supply of high energy compounds. Past studies have demonstrated that D-ribose supplementation enhances the return of ATP levels with an associated improvement in diastolic function."

D-Ribose, unlike glucose, is a five-carbon sugar important for DNA, RNA, and most importantly, ATP, the "energy currency" of the cells. ATP is crucial in maintaining the integrity and function of every cell, which is necessary for day- to-day health. Ribose is one of the essential components of the ATP molecule.

D-Ribose, as a supplement, has repeatedly shown to improve functional capacity, quality of life, and everyday activities for patients afflicted with congestive heart failure.

Dr. Neubauer's article, "The Failing Heart - An Engine Out of Fuel," calls attention to the important underlying metabolic problem in patients with heart failure. "D-ribose could aid in this metabolic deficiency," said Dr. St. Cyr. "The number of heart failure patients continues to grow every year. By replenishing ATP to an energy-deficient heart we can significantly improve a patient's quality of life."

Bioenergy Inc. is a privately held, Minneapolis-based life sciences company whose core technology lies in the development and commercialization of products based on the physiological benefits of D-ribose in health and wellness. Bioenergy's clear mission is to develop products that increase the quality of its customers' lives by improving their metabolic health. Bioenergy Life Science, Inc., its subsidiary, markets ribose-based products to the functional food and clinical nutrition markets. Bioenergy Life Science products include Bioenergy RIBOSE(TM) , a functional ingredient in the active lifestyle market; Corvalen(R), and CorvalenM(R), clinical nutrition products giving metabolic support to patients with heart and muscle disease.

Bioenergy Inc.

CONTACT: Dean Draznin, +1-641-472-2257, or dean@drazninpr.com , or LeslieLevine, +1-847-205-9853, or leslie@drazninpr.com , both of Dean DrazninCommunications, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES